​***If you do not receive your event confirmation within 1 business day of RSVPing (above), check your email spam folder. The automated Luma email includes the Zoom info and cal invite.***

​Comm Convo pricing:

• ​Complimentary for T2B Pro and Student community members (log into your T2B account and access your promo code here)

• ​$40 for Basic members (access to live event only, not the recording)

​If you're not part of Ticket to Biotech, confirm you're eligible, and join before registering for this event:

​T2B Intake Form

​NOVEMBER COMM CONVO: DEFINING "CORPORATE AFFAIRS" IN A CROWDED SPACE

​Corporate affairs in biopharma no longer has clearly drawn borders. Functions like medical affairs, HR, policy, and market access now play increasing roles in how organizations communicate, and many colleagues consider themselves communicators simply because they’ve spoken at a conference, represented the company at an event, or built their own channels. Rather than defending turf, the best communications leaders are focused on defining scope with intention: determining where to lead, where to collaborate, and where to let others take the mic. This month’s Comm Convo explores how to sustain the distinctive value of corporate affairs while building partnerships across functions and maintaining the strategic authority that keeps the enterprise aligned.

​WHY ATTEND

• ​Assess when to lead, collaborate, or step back in areas where multiple functions claim communications territory.

• ​Exchange strategies for defining the role of corporate affairs without alienating colleagues who want to contribute.

• ​Consider approaches to empower others while reinforcing the function’s credibility and strategic influence.

• ​Articulate what corporate affairs uniquely provides when overlapping initiatives arise elsewhere in the organization.

​MEET OUR SPEAKERS

​Erin Schellhammer, Chief People Officer, Cogent Biosciences

​Erin Schellhammer is an accomplished HR executive with over 20 years of experience in the biotechnology and pharmaceuticals industry. She currently serves as the Chief People Officer at Cogent Biosciences where she worked on building the company from the ground up.  Previously she was the CPO for Unum Therapeutics, the Head of HR at Intellia Therapeutics and at Biogen holding various global HR positions.  With a passion for building organizations, Erin has accumulated valuable HR experience, working across the spectrum from discovery to commercial organizations. Her commitment to fostering leadership and helping leaders find their voice is a testament to her dedication to developing and supporting talent within the industry.  Outside of her professional endeavors, Erin enjoys a variety of hobbies including playing music, food, and travel.